Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Sukhtian Ghiath M.
Over the trailing 90 days, Sukhtian Ghiath M. (Other at Outlook Therapeutics, Inc.) bought $5.0M of stock in OTLK, per 7 SEC Form 4 transactions.
- Role
- Other
- Companies
- OTLK
- Window
- Trailing 90 days · 7 transactions · CIK 1717441
- Net activity
- +$5.0M ($5.0M bought · $0 sold)
By Company (Trailing 90 Days)
| Symbol | Company | Txns | Bought | Sold | Net |
|---|---|---|---|---|---|
| OTLK | Outlook Therapeutics, Inc. | 7 | $5.0M | — | $5.0M |
Transactions (7)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-05-28 | OTLK | Buy | 8.6M | $0 | Open market or private purchase |
| 2026-05-28 | OTLK | Buy | 8.5M | $5.0M | Open market or private purchase |
| 2026-05-28 | OTLK | Sell | 3.5M | $0 | Unknown transaction code: H |
| 2026-05-28 | OTLK | Buy | 3.5M | $0 | Open market or private purchase |
| 2026-05-28 | OTLK | Sell | 3.5M | $0 | Unknown transaction code: H |
| 2026-05-28 | OTLK | Buy | 3.5M | $0 | Open market or private purchase |
| 2026-05-28 | OTLK | Sell | 8.6M | $0 | Unknown transaction code: H |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Sukhtian's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.